Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • SC Quashes Substandard...

SC Quashes Substandard Rabeprazole Case Against Indica Labs, Cites Limitation Bar

Susmita RoyWritten by Susmita Roy Published On 2025-09-24T19:06:07+05:30  |  Updated On 24 Sept 2025 7:06 PM IST
Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI

SC

  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The Supreme Court of India has set aside criminal proceedings initiated against directors of Indica Laboratories Pvt. Ltd., holding that the complaints filed against them for allegedly selling substandard Rabeprazole tablets were barred by limitation under the Code of Criminal Procedure (CrPC).

The apex court clarified that for offenses under the Drugs and Cosmetics Act, 1940 carrying a maximum imprisonment of three years, the limitation period begins from the date of receipt of the Government Analyst’s report.

A Bench of Justice Vikram Nath and Justice Sandeep Mehta allowed the appeals filed by Miteshbhai J. Patel and another, challenging the Kerala High Court’s judgment dated December 5, 2023, which had upheld the Trial Court’s decision to continue proceedings against them.

On 29 January 2010, the Drug Inspector collected samples of Rabeprazole tablets from City Medicals in Kozhikode. The drug, manufactured by Indica Laboratories Pvt. Ltd., was tested in a government laboratory, and reports dated 30 March 2010 and 9 April 2010 declared it “not of standard quality” for failing the tests of Related Substances and Assay.

Based on these reports, two complaints (CC 1/2014 and CC 2/2014) were filed against the company’s directors under Section 32 of the Drugs and Cosmetics Act, 1940, alleging violations of Section 18(a)(i), punishable under Section 27(d).

The appellants challenged these complaints, arguing that they were filed beyond the three-year limitation period prescribed under Section 468(2)(c) CrPC.

In 2018, the Trial Court rejected their plea, holding that the delay was justified as time was required to issue prosecution notices and collect details of the accused.

The Kerala High Court, in December 2023, upheld this reasoning. However, the Supreme Court disagreed, holding that the limitation period began from the dates of the drug analyst’s reports, 30 March 2010 and 9 April 2010, and since the complaints were filed only on 24 June 2013 and 3 July 2013, they were beyond the statutory three-year period.

Consequently, the court observed;

"Section 468(2) of the Code of Criminal Procedure prescribes the period of limitation and states that for any offense that is punishable with a term exceeding one year but not exceeding three years, the period of limitation shall be three years. The punishment prescribed under Section 27 of the 1940 Act for the offense of manufacturing or distributing substandard drugs is three years. Therefore, any complaint disclosing such an offense ought to have been made within a period of three years. Section 469(a) of the CrPC provides that the period of limitation in relation to an oCence commences on the date of the offense.

The Court further noted that the company’s particulars were already available in the Government Analyst’s reports and even communicated to the company in 2010, leaving no justification for the delay.

"In the present case, it is not disputed that the complaints were filed much later than three years from the date of the reports submitted by the drug analyst. As is the nature of this case, an offense would be made out only after the report of the drug analyst is received.

As the drug analyst reports in the present case were received on 30.03.2010 and 09.04.2010, therefore, the limitation period by virtue of Section 469(a) of CrPC shall commence from that respective date when the said reports were received. The complaint is filed by the respondents only on 24.06.2013 and 03.07.2013, which is beyond the statutory time limit."

It also observed that neither the Trial Court nor the High Court could have condoned the delay when no such request was made.

Referring to the principle “vigilantibus non dormientibus jura subveniunt” (law helps the vigilant, not the indolent), the Supreme Court concluded that the prosecution had sufficient time to act but failed to do so.

The Court ruled that the proceedings were barred by limitation and quashed the complaints, noting,

"In view of the above discussion, we are of the firm view that the impugned proceedings were barred by limitation and thus deserve to be quashed."
"Although other grounds such as not conducting a mandatory enquiry as per Section 202 CrPC were raised, we are not inclined to deal with them since the ground of limitation is good enough to allow the appeal."
"Accordingly, the appeals stand allowed. The impugned judgment of the High Court is set aside and the proceedings arising from the complaint are quashed."

To view the official order, click the link below:

https://medicaldialogues.in/pdf_upload/order-72382024-29-07-2025-616441-298422.pdf
not of standard qualityrabeprazolDrug and Cosmetic Actindica laboratoriesSupreme Court of IndiaIndica labs
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Show Full Article
    Next Story

    Editorial

    EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

    EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

    PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic Alopecia-Combination Shows Superior Efficacy

    PRO-ACT Study Compares Topical Minoxidil 5% with PRCT vs Plain Minoxidil 5% in Androgenetic...

    DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin-  Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology  Settings

    DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV...

    Indias Unique CV Risk Profile: How to Decode the Role of Aspirin?

    India's Unique CV Risk Profile: How to Decode the Role of Aspirin?

    Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest DAa-ViNCI Study

    Vildagliptin-Dapagliflozin FDC Effective in High CV Risk Indian T2DM Patients: Findings from Latest...

    View All

    Journal Club Today

    Mediterranean Diet and Lifestyle Changes Cut Type 2 Diabetes Risk by 31 Percent: Study Finds

    Mediterranean Diet and Lifestyle Changes Cut Type 2 Diabetes Risk by 31 Percent: Study Finds

    View All

    Health News Today

    Health Bulletin 18/October/2025

    Health Bulletin 18/October/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok